Gregory Pepin's  Instablog

Gregory Pepin
Send Message
Gregory Pepin is a co-partner of a Wealth Management company in switzerland. He has a Master of Science degree in Finance and Actuary Science from HEC Lausanne (Switzerland). He also teaches Finance at the University of St. Joseph (Lebanon). Gregory is a strong believer of the Graham Theory that... More
  • Oxygen Biothérapeutics Deal Update 2 comments
    Jul 16, 2009 8:52 AM | about stocks: TENX

    Today, Oxygen Biothérapeutics announced :

    COSTA MESA, Calif., July 16 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bullletin Board: OXBO) today announced that the company has closed on the first $5 million financing tranche with the Vatea Fund, Segregated Portfolio under a June 8, 2009 securities purchase agreement (source)


    As a manager of Vatea Fund, Segregated Portofolio, i'm very excited about the long term collaboration we are building between this Biotech and us.

    These is just the beginning of a great story.

    We have many reason to be confident about the future of Oxygen Biothérapeutics :

    - Potential of Topical Product : Wound treatment, Burn treatment, Rosacea, Acne and perhaps more and more usage as Oxygen play a major role in skin treatment.

    - Traumatic Brain Injury potential : Oxycyte could be a blockbuster product for Traumatic Brain Injury if all trial goes well. The market ahead is just unbelievable.

    - PHIL Laboratory : This Laboratory opens the doors to many other potential usage for Oxycyte : Spinal Cord, Heart Attack etc. This laboratory will allow Oxygen Biothérapeutics to study potential positive effect of Oxycyte on other case then Traumatic Brain Injury. If those study provide positive outcome, it will be a great news for the troops and in general everyone. The potential of Oxycyte is pretty unlimited now and PHIL laboratory will allow the researcher to try to use the full potential of this great product.

    - NAVY agreement : The NAVY will finance and study on their side the potential usage of Oxycyte for Decompression sickness. This could mean : A new market for Oxygen Biotherapeutics without the cost of research that will be handle by the NAVY.

    - The great quality of the Management and the research team : No one can predict the result of clinical trial. We can only have some assumption and also we can evaluate the potential market looking forward if the trial works. But there is at least one thing we can evaluate, it's the management team and the research team. In the case of Oxygen Biothérapeutics, i have to say that we like a lot the Management and research team, we do believe that it is a top level group that can be value as a great asset to the company and knows how to manage over the long term the company. This is one of the major reason why we wanted to be partner with them and give them the tools and the shareholders stability to develop the company.

    etc. etc.


    There is plenty of reason that justify our decision to be a long term partner with Oxygen Biotherapeutics. This morning news is just the beginning of a great long term growth story that we are glad to be part of.

    Disclosure : My Fund owns shares of Oxygen Biotherapeutics

    Stocks: TENX
Back To Gregory Pepin's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • Clay B
    , contributor
    Comments (9) | Send Message
    Thank you for your update. I agree, this is a very exciting time to be a part of the company. I think oxycyte will be able to deliver what it promises. I also think there maybe boader applications of this drug that haven't been discovered yet. I hope orphan drug approval happens, a deal with the topical is announced this year and the trials commence shortly.
    As a shareholder i have to thank you for your investment as it really provides stability to the company and they can focus on development and not have to worry about going out of business due to lack of funds. I don't know if fellows shareholders realize just how important your fund's investment truely is.
    Good luck to all!
    20 Jul 2009, 06:31 PM Reply Like
  • Gregory Pepin
    , contributor
    Comments (120) | Send Message
    Author’s reply » We decided to invest in the company because we have great expectation over the long term. We really like the management and potential of oxycyte both as an oxygen carrier and also as a topical product. We really do feel that this management is doing a great job and is executing very well and has a very attractive business plan.
    23 Jul 2009, 12:04 PM Reply Like
Full index of posts »
Latest Followers


  • No fundamentals in the economy support the actual bullish move in the market. The market is on steroids... Liquidity bubble will burst soon.
    Oct 8, 2010
  • Well on my instablog of may 09 i predicted a new line of product with Apple Chip Apple Battery Iphone OS etc. Will buy it for sure
    Jan 27, 2010
  • In may 09, i wrote an instablog about a new line of Apple product using Iphone OS. Today is just the beginning
    Jan 27, 2010
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.